The brilliant minds revolutionizing cardiovascular health through innovation and expertise
Overseeing stakeholder engagement
Mr. Cresswell is the founder and managing partner of New Enterprise Ventures. Over the past 25+ years, he has built healthcare companies, new business models, partnerships, and joint ventures. He has supported high-profile clients including Walmart Health & Wellness and Quest Diagnostics.
With over 30 years of experience leading technology companies across 15 countries, Mr. Krishnan has launched social ventures in underserved communities worldwide and holds several USPTO patents. He completed his Engineering studies at both IIT Madras and Cornell University.
A professor at IIT Madras and leader of the Healthcare Technology Innovation Centre, Dr. Sivaprakasam has transformed HTIC into a premier med-tech hub. He spearheads interdisciplinary research and development programs focused on disadvantaged communities.
Mr. O'Grady is an experienced corporate lawyer with significant transactional and international experience. Mr. O'Grady was a partner at the law firm of McGuire Woods LLP, where he practiced for 27 years. Before that, he practiced law in Johannesburg, South Africa with Bowman Gilfillan, one of Africa's largest law firms, and with Shearman & Sterling, in New York.
Expert medical guidance from industry leaders
Medical Director at UMD & Medstar and Oncologist with deep expertise in AI-enabled healthcare solutions.
Medical Science Liaison at Apellis Pharmaceuticals, Sustainability Expert, and Ophthalmologist.
Ms. Demyanovich brings over a decade of experience in clinical research, with a strong focus on patient-centered outcomes and healthcare innovation. As Research Director at UM Capital Region Health, she leads clinical trials and oversees protocol development.
Leading strategic direction and operations
Mr. Pillai brings over 20 years of leadership in healthcare and life sciences. As the founder and CEO of Ulivmo, LLC., he built and scaled digital health ventures focused on smart, connected care services. His expertise spans autoimmune, cardiovascular, chronic pain, and metabolic diseases.
Ms. Soni, Chief Compliance Officer, has over 25 years of experience in operations management, human resources management and project administration. She excels in setting up and managing back office and project management structures, focusing on delivering cost control and operational efficiencies.
15+ years of experience in medical device innovation, 15+ patents, 230+ publications, & award-winning technologies like ARTSENSĀ®.
Dr. Karudapuram is an accomplished biotech leader with over 15 years of experience driving strategy, product launches, and demand generation across genomics, clinical platforms, and oncology medical devices. She has successfully launched instruments, consumables, software, and medical devices.
Driving brand growth and market expansion
Healthcare AI Analyst with expertise in AI-driven healthcare and preventative risk communication.
Marketing Specialist with expertise in healthcare communications, brand positioning, and digital strategy.
Yashwini creates visually compelling stories and purpose-driven solutions that merge creative entrepreneurship with social impact.
Meghna leverages her unique blend of clinical insight and technical expertise to create innovative, patient-focused health technology solutions.
Innovation and technical excellence driving our products
Life sciences innovation leader and cardiovascular scientist recognized for pioneering research with global impact.
Innovator and cardiovascular technology expert with R&D and product development, driving advancements in vascular health.
AI Engineer specializing in LLMs, agentic systems, and multi-modal RAG pipelines with expertise in reducing hallucinations and optimizing model performance.
Data scientist with expertise in AI, machine learning, and data analytics.
The technology behind VascRisk's flagship device, ARTSENSĀ®, was developed at the Indian Institute of Technology Madras (IITM), which has been at the forefront of cutting-edge research in affordable healthcare. In 2023, VascRisk secured a technology transfer agreement with IIT Madras, ensuring exclusive rights to ARTSENSĀ®.
Our close collaboration with IIT Madras continues through our board members who maintain strong ties with the institution. This academic partnership ensures that VascRisk benefits from the latest research advancements and maintains the highest standards of technological innovation.
We're always looking for talented individuals who share our passion for innovation and improving healthcare outcomes. If you're interested in joining our team, we'd love to hear from you.
Join Our Team